Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Total Debt (2019 - 2025)

Cresco Labs' Total Debt history spans 7 years, with the latest figure at $427.9 million for Q4 2025.

  • For Q4 2025, Total Debt fell 7.63% year-over-year to $427.9 million; the TTM value through Dec 2025 reached $427.9 million, down 7.63%, while the annual FY2025 figure was $427.9 million, 7.63% down from the prior year.
  • Total Debt reached $427.9 million in Q4 2025 per CRLBF's latest filing, down from $463.2 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $509.5 million in Q4 2023 to a low of $427.9 million in Q4 2025.
  • Average Total Debt over 5 years is $474.7 million, with a median of $485.0 million recorded in 2021.
  • Peak YoY movement for Total Debt: soared 72.38% in 2021, then decreased 9.09% in 2024.
  • A 5-year view of Total Debt shows it stood at $485.0 million in 2021, then increased by 0.59% to $487.9 million in 2022, then grew by 4.44% to $509.5 million in 2023, then fell by 9.09% to $463.2 million in 2024, then decreased by 7.63% to $427.9 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Total Debt are $427.9 million (Q4 2025), $463.2 million (Q4 2024), and $509.5 million (Q4 2023).